Tilray Brands, INC 8-K filings

Tilray Brands announced the issuance of 1,377,334 shares of common stock in exchange for $6 million in convertible senior notes.

Tilray Brands announced record fiscal year 2026 revenue of $915 million and record Adjusted EBITDA, driven by strong performance in its cannabis, beverage, and distribution segments, with a positive outlook for fiscal year 2027.

Tilray Brands issued over 2.6 million shares of common stock to settle $12 million in convertible notes.

Tilray Brands announced a debt-for-equity exchange, issuing 1,214,186 shares of common stock for $6 million in convertible notes.

Tilray Brands, Inc. has filed a prospectus supplement for the resale of 398,666 shares of its common stock.

Tilray Brands announced an at-the-market equity program of up to $180 million to fund global beverage expansion and strategic initiatives, including the acquisition of UK-based Lyphe Group.

Tilray Brands reported record third-quarter fiscal 2026 net revenue of $206.7 million and gross profit of $55.0 million, driven by strong international cannabis growth and strategic beverage acquisitions.

Tilray Brands has acquired key assets of BrewDog for £33 million, creating a significant global craft beer and beverage platform expected to generate $200 million in annual net revenue.

Tilray Brands reported record Q2 fiscal 2026 net revenue of $218 million, moved to a net cash position, and reaffirmed its full-year Adjusted EBITDA guidance.

Tilray Brands, Inc. will implement a one-for-ten reverse stock split effective December 1, 2025, to align shares, attract institutional investors, and reduce costs.

Tilray Brands, Inc. stockholders approved three proposals, including director re-election and auditor ratification, but rejected a key governance change to declassify the Board at their 2025 annual meeting.

Tilray Brands, Inc. announced it has furnished an investor presentation dated November 17, 2025, making it available on its website.

Tilray Brands reports strong first quarter fiscal 2026 results, achieving record Q1 net revenue of $210 million and net income, alongside significant balance sheet strengthening.

Tilray Brands, Inc. filed a legal opinion confirming the valid issuance of up to 6.2 million common shares upon warrant exercise.

Tilray Brands reported a significant net loss for fiscal year 2025 due to a substantial non-cash impairment charge, despite achieving overall revenue growth and strategic advancements across its cannabis, beverage, and wellness segments.

Tilray Brands, Inc. announced a private debt-for-equity exchange, issuing over 12.5 million common shares to retire $5 million of its 5.20% Convertible Senior Notes due 2027.

Tilray Brands, Inc. stockholders approved a proposal to amend the company's certificate of incorporation to effect a reverse stock split of its common stock by a ratio of one-for-ten to one-for-twenty, granting the Board of Directors discretion on implementation.

Tilray Brands issued over 19 million shares of common stock in exchange for $9.4 million of convertible senior notes.

Tilray Brands announces a special meeting of stockholders to vote on a reverse stock split proposal to improve its stock price and attract institutional investors.

Tilray Brands reports net revenue of $186 million in Q3 2025, with strategic initiatives impacting revenue by $13 million, while also reducing debt and expanding U.S. distribution of hemp-derived THC drinks.

Tilray Brands, Inc. received a notification from Nasdaq on March 25, 2025, indicating non-compliance with the minimum bid price requirement for continued listing.

Tilray Brands plans to issue up to 23 million shares of common stock in exchange for $14.6 million of its convertible senior notes.

Aphria Diamond Inc., a subsidiary of Tilray Brands, refinanced its existing term loan by entering into a new CAD $53 million credit agreement with Canadian Imperial Bank of Commerce.

Tilray Brands settles a Canadian class action lawsuit related to Aphria's past acquisitions for CAD $30 million, avoiding a trial scheduled for January 2025.

Tilray Brands will issue up to 21 million shares of common stock in exchange for $22 million of convertible senior notes.

Tilray Brands achieved record Q2 net revenue of $211 million, driven by growth across all business segments and a 29% increase in gross profit year-over-year.

Tilray Brands' stockholders have approved an increase in the number of authorized shares from 1,208,000,000 to 1,426,000,000 at their reconvened annual meeting on December 19, 2024.

Tilray Brands has appointed Steven M. Cohen, a seasoned legal and business professional, to its board of directors, effective immediately.

Tilray Brands successfully defended a lawsuit challenging the voting standard used for its share authorization proposals, and will proceed with its adjourned annual meeting on December 19, 2024.

Tilray Brands held its 2024 annual meeting, approving the election of two Class III directors and the ratification of its accounting firm, while adjourning the vote on increasing authorized shares due to pending litigation.